Alternatives to Dotmatics

SciSpace BioMed Agent runs multi-omics, variant prioritization, and drug repurposing analysis from plain-language biomedical prompts.

Silico is Goodfire's mechanistic interpretability agent for understanding, debugging, and steering the internals of your AI models.

Oncology real-world evidence built from point-of-care patient data, with AI-powered analysis layered on top.

Causal AI drug discovery that pairs 20+ petabytes of cellular data with human genetics to find real disease targets

Novaflow is an AI data analyst that runs scRNA-seq, spatial, and multi-omics pipelines from raw data to publication-ready figures and

Frekils is AI agents for real-world evidence studies — cohorts, SAPs and publication-ready statistics on your own clinical data.

Owkin's K Pro is an autonomous AI scientist for drug discovery and clinical trial decisions, built on multimodal patient data

All-in-human foundation models that read a routine blood draw to predict brain activity, therapy response, and side effects in neurology.

Benchling unifies ELN, LIMS, and AI agents for biotech R&D in one cloud platform.

Recursion runs AI drug discovery as a lab-in-the-loop engine — automated cellular imaging at scale feeding generative chemistry and a clinical pipeline.

Recursion's AI drug discovery platform pairing 2M weekly wet-lab experiments with a 50+ PB proprietary dataset, now incorporating Exscientia.

Automated cloud lab for protein validation — binding, expression and thermostability assays with data back in as little as 3 days

Project-based AI biopharma team that delivers decision-grade research, analysis, and computational design in 3–5 days.

Delineate assembles clinical pharmacology evidence into MBMA databases and models for dose optimization and go/no-go decisions.

Lamin is a lineage-native open data platform with the LaminDB library for traceable, multimodal biotech data — query, govern, and version

AI-driven scientific diligence software for pharma BD, biotech and life science investors evaluating in-licensing, M&A and investment

AI-native pharma company using autonomous agents to find new uses for existing drugs and predict patient drug response

BioStack Platforms supplies structured clinical datasets and RL environments for healthcare AI teams.

PicnicAI turns patient health records into clinical research data and real-world evidence.

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

Clinical-stage techbio company pairing automated wet labs with AI models to discover and develop drugs.

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Clinical-stage biotech designing highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

Iktos pairs generative AI for small-molecule design with AI retrosynthesis and robotic lab automation.

Renamed: Deep 6 AI was acquired by Tempus AI in March 2025 and its trial matching folded into Tempus.

Physics-based molecular simulation with AI for drug discovery and materials design.

FDA-cleared AI for cancer pathology on H&E slides, plus the Virchow and PRISM foundation models licensed to biopharma and researchers.

Quibim turns MRI, CT and PET scans into cleared, quantitative imaging biomarkers for prostate, brain, liver, breast and lung.

Tempus pairs tumor DNA/RNA sequencing with AI precision oncology analytics to surface treatment and trial matches